Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2017, ended Feb 3, 2017 | $50.0B |
| FY2018, ended Feb 2, 2018 | $54.5B |
| FY2019, ended Feb 1, 2019 | $35.7B |
| FY2020, ended Jan 31, 2020 | $36.1B |
| FY2021, ended Jan 29, 2021 | $55.6B |
| FY2022, ended Jan 28, 2022 | $42.8B |
| FY2023, ended Feb 3, 2023 | $30.9B |
| FY2024, ended Feb 2, 2024 | $61.6B |
| FY2025, ended Jan 31, 2025 | $72.3B |
| FY2026, ended Jan 30, 2026 | $73.9B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $258B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2017, ended Feb 3, 2017 | $62.2B |
| FY2018, ended Feb 2, 2018 | $79.0B |
| FY2019, ended Feb 1, 2019 | $90.6B |
| FY2020, ended Jan 31, 2020 | $84.8B |
| FY2021, ended Jan 29, 2021 | $86.7B |
| FY2022, ended Jan 28, 2022 | $101B |
| FY2023, ended Feb 3, 2023 | $102B |
| FY2024, ended Feb 2, 2024 | $88.4B |
| FY2025, ended Jan 31, 2025 | $95.6B |
| FY2026, ended Jan 30, 2026 | $114B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $151B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2017, ended Feb 3, 2017 | −$1.17B | $1.67B |
| FY2018, ended Feb 2, 2018 | −$2.85B | $5.63B |
| FY2019, ended Feb 1, 2019 | −$2.31B | $5.49B |
| FY2020, ended Jan 31, 2020 | $4.62B | $6.71B |
| FY2021, ended Jan 29, 2021 | $3.25B | $9.32B |
| FY2022, ended Jan 28, 2022 | $5.56B | $7.51B |
| FY2023, ended Feb 3, 2023 | $2.44B | $562M |
| FY2024, ended Feb 2, 2024 | $3.39B | $5.92B |
| FY2025, ended Jan 31, 2025 | $4.59B | $1.87B |
| FY2026, ended Jan 30, 2026 | $5.94B | $8.55B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $11.4B | $8.56B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2017, ended Feb 3, 2017 | $9.47B |
| FY2018, ended Feb 2, 2018 | $13.9B |
| FY2019, ended Feb 1, 2019 | $9.68B |
| FY2020, ended Jan 31, 2020 | $9.30B |
| FY2021, ended Jan 29, 2021 | $9.51B |
| FY2022, ended Jan 28, 2022 | $9.48B |
| FY2023, ended Feb 3, 2023 | $8.61B |
| FY2024, ended Feb 2, 2024 | $7.37B |
| FY2025, ended Jan 31, 2025 | $3.63B |
| FY2026, ended Jan 30, 2026 | $11.5B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $11.6B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2017, ended Feb 3, 2017 | $49.4B |
| FY2018, ended Feb 2, 2018 | $51.9B |
| FY2019, ended Feb 1, 2019 | $53.5B |
| FY2020, ended Jan 31, 2020 | $52.1B |
| FY2021, ended Jan 29, 2021 | $39.2B |
| FY2022, ended Jan 28, 2022 | $27.0B |
| FY2023, ended Feb 3, 2023 | $29.6B |
| FY2024, ended Feb 2, 2024 | $26.0B |
| FY2025, ended Jan 31, 2025 | $24.6B |
| FY2026, ended Jan 30, 2026 | $31.5B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $34.5B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 18.1% since FY17.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2017, ended Feb 3, 2017 | 776M |
| FY2018, ended Feb 2, 2018 | 769M |
| FY2019, ended Feb 1, 2019 | 719M |
| FY2020, ended Jan 31, 2020 | 739M |
| FY2021, ended Jan 29, 2021 | 763M |
| FY2022, ended Jan 28, 2022 | 760M |
| FY2023, ended Feb 3, 2023 | 731M |
| FY2024, ended Feb 2, 2024 | 714M |
| FY2025, ended Jan 31, 2025 | 698M |
| FY2026, ended Jan 30, 2026 | 646M |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | 636M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2017, ended Feb 3, 2017 | $611M | $398M | $4.42B |
| FY2018, ended Feb 2, 2018 | $724M | $835M | $0 |
| FY2019, ended Feb 1, 2019 | $14.1B | $918M | — |
| FY2020, ended Jan 31, 2020 | $8.00M | $1.26B | — |
| FY2021, ended Jan 29, 2021 | $241M | $1.61B | — |
| FY2022, ended Jan 28, 2022 | $1.50B | $1.62B | — |
| FY2023, ended Feb 3, 2023 | $2.88B | $931M | — |
| FY2024, ended Feb 2, 2024 | $2.08B | $878M | $10.0M |
| FY2025, ended Jan 31, 2025 | $2.59B | $785M | $1.00M |
| FY2026, ended Jan 30, 2026 | $6.01B | $723M | $5.00M |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $8.52B | $727M | — |
Valuation
At current price- Market Cap
- $319B
- P/E
- 28.0×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.1×
- Price / Book
- n/m. Market cap / shareholders' equity
- EV / EBITDA
- 19.8×
Growth
Trailing 12 months- Revenue (TTM)
- $151B
- Revenue Growth YoY
- 49.0%
- Revenue CAGR 3Y
- 3.5%
- Revenue CAGR 5Y
- 5.5%
- EPS Growth YoY
- 151%
- Net Income Growth YoY
- 135%
Profitability
Trailing 12 months- Gross Margin
- 19.8%
- Operating Margin
- 9.4%
- Net Margin
- 7.5%
- FCF Margin
- 5.7%
- Return on Equity
- n/m. Net income (TTM) / average equity
Earnings
Trailing 12 months- Net Income
- $11.4B
- EPS (diluted)
- $17.19
- EBITDA
- $17.3B
- Operating Income
- $14.3B
Balance Sheet
As of Jul 31, 2026- Cash and cash equivalents
- $11.6B
- Total Debt
- $34.5B
- Net Debt
- $22.9B
- Total Assets
- $127B
- Total Liabilities
- $129B
- Shareholders' Equity
- −$1.43B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $12.2B
- Capital Expenditure
- $3.59B
- Free Cash Flow
- $8.56B
Dividends and risk
Last 12 months- Dividend Yield
- 0.5%
- Dividend / Share
- $2.42
- Beta (5Y)
- 1.37
Every ratio is calculated from the company’s reported figures.